Molecular Partners AG
MOLN
$3.80
-$0.09-2.31%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -91.14% | -67.23% | -27.77% | -27.91% | -0.95% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -91.14% | -67.23% | -27.77% | -27.94% | -1.29% |
| Cost of Revenue | -13.35% | -8.28% | 1.26% | 9.72% | 13.58% |
| Gross Profit | -0.96% | -1.09% | -6.24% | -18.15% | -16.82% |
| SG&A Expenses | -3.96% | -4.88% | -6.06% | -4.26% | -7.69% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -10.78% | -7.32% | -0.92% | 5.46% | 6.84% |
| Operating Income | 0.56% | 0.78% | -2.16% | -10.32% | -7.97% |
| Income Before Tax | -15.74% | -1.61% | 11.10% | -9.44% | 1.11% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -15.74% | -1.61% | 11.09% | -9.44% | 1.11% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.74% | -1.61% | 11.09% | -9.44% | 1.11% |
| EBIT | 0.56% | 0.78% | -2.16% | -10.32% | -7.97% |
| EBITDA | 0.49% | 0.71% | -2.16% | -10.60% | -8.03% |
| EPS Basic | -5.80% | 4.15% | 13.84% | -8.32% | 2.07% |
| Normalized Basic EPS | -1.50% | 4.16% | 13.85% | -8.30% | 2.08% |
| EPS Diluted | -5.91% | 4.04% | 13.74% | -8.32% | 2.08% |
| Normalized Diluted EPS | -1.50% | 4.16% | 13.85% | -8.30% | 2.08% |
| Average Basic Shares Outstanding | 9.57% | 6.65% | 3.85% | 1.02% | 0.99% |
| Average Diluted Shares Outstanding | 9.57% | 6.65% | 3.85% | 1.02% | 0.99% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |